Dr. Vandermolen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Old Newport Blvd
Newport Beach, CA 92663Phone+1 949-646-6441Fax+1 949-646-5719
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
- Baylor College of MedicineFellowship, Hematology, 1983 - 1984
- Methodist Hospital (Houston)Chief Residency, Internal Medicine, 1983 - 1984
- Baylor College of MedicineResidency, Internal Medicine, 1980 - 1983
- Loyola University Chicago Stritch School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1983 - 2025
- AR State Medical License 1986 - 1991
- MD State Medical License 1987 - 1991
- TN State Medical License 1989 - 1990
- TX State Medical License 1981 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 3 citationsThe integration of high-dose chemotherapy and biotherapy: initial 5-year experience with autologous bone marrow transplantation in a comprehensive community cancer cen...Robert O. Dillman, Neil M. Barth, Khosrow Mahdavi, Louis A. VanderMolen, Shankar K. Nayak
Cancer Biotherapy. 1995-01-01 - 4 citationsErythrocytosis in hairy cell leukaemia following therapy with interferon alpha.Ronald G. Steis, Louis A. VanderMolen, Jeffry B. Lawrence, Garwin K. Sing, Frank Ruscetti
British Journal of Haematology. 1990-05-01 - 19 citationsTreatment of kidney cancer with autologous tumor cell vaccines of short-term cell lines derived from renal cell carcinoma.Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen, David H. Garfield, Cristina de Leon
Cancer Biotherapy & Radiopharmaceuticals. 2001-02-01
Press Mentions
- Almost 20% of Breast Cancer Survivors May Experience Excess Weight Gain, Study ReportsJune 6th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: